In non-small cell lung cancer, lncRNA AGAP2-AS1 acts as an oncogene that inhibits the expression of large tumor suppressor kinase 2 (LATS2) and Kruppel-like factor 2 (KLF2) via interacting with EZH2 and LSD1 [6]. This evidence concerns the gene LATS2 and non-small cell lung carcinoma.